Benzinga | Aug 10, 2021 05:09AM EDT

Raymond James Downgrades ZIOPHARM Oncology to Market Perform, Announces $3 Price Target

Raymond James analyst David Novak downgrades ZIOPHARM Oncology (NASDAQ:ZIOP) from Outperform to Market Perform and announces $3 price target.